Aldeyra Therapeutics Inc(ALDX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ALDX Aldeyra Therapeutics Inc

交易中 03-24 12:51:51 EDT

1.98

-0.25

-11.21%

最高2.33	最低1.95	成交量376.76万
今开2.25	昨收2.23	日振幅17.04%
总市值1.19亿	流通市值9,599万	总股本6,016万
成交额802.88万	换手率7.77%	流通股本4,848万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ALDX","market":"US","secType":"STK","nameCN":"Aldeyra Therapeutics Inc","latestPrice":1.98,"timestamp":1774371108014,"preClose":2.23,"halted":0,"volume":3767583,"delay":0,"changeRate":-0.11210762331838565,"floatShares":48481525,"shares":60162773,"eps":-0.563579,"marketStatus":"交易中","change":-0.25,"latestTime":"03-24 12:51:51 EDT","open":2.25,"high":2.33,"low":1.95,"amount":8028840.689172599,"amplitude":0.170404,"askPrice":1.98,"askSize":1110,"bidPrice":1.97,"bidSize":2803,"shortable":0,"etf":0,"ttmEps":-0.563579,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1774382400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1399003200000,"exchange":"NASDAQ","adjPreClose":2.23,"preHourTrading":{"tag":"盘前","latestPrice":2.29,"preClose":2.23,"latestTime":"09:29 EDT","volume":137379,"amount":324956.42397899996,"timestamp":1774358956920,"change":0.06,"changeRate":0.026906,"amplitude":0.09417},"postHourTrading":{"tag":"盘后","latestPrice":2.2212,"preClose":2.23,"latestTime":"19:54 EDT","volume":72134,"amount":160626.4917,"timestamp":1774310095339,"change":-0.0088,"changeRate":-0.003946,"amplitude":0.017937},"volumeRatio":0.367569,"impliedVol":1.3906,"impliedVolPercentile":0.5618},"requestUrl":"/m/hq/s/ALDX/tweets","defaultTab":"tweets","newsList":[{"id":"1156733045","title":"Aldeyra Therapeutics股价创历史新低，美国FDA拒绝批准其眼疾药物，盘中暴跌70%","url":"https://stock-news.laohu8.com/highlight/detail?id=1156733045","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156733045?lang=zh_cn&edition=full","pubTime":"2026-03-17 21:50","pubTimestamp":1773755416,"startTime":"0","endTime":"0","summary":"由于美国食品药品监督管理局（FDA）拒绝批准其治疗眼部疾病的药物，Aldeyra Therapeutics Inc (ALDX) 的股价遭受重创，跌至历史最低点。盘中交易时段，该股跌幅一度高达70%，市场反应极为剧烈。\n这一监管决定对公司的短期前景造成了重大打击，投资者信心严重受挫。股价的急剧下跌反映了市场对于该药物获批前景的突然转向以及公司未来收入预期的重新评估。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALDX","BK4139"],"gpt_icon":0},{"id":"1118608837","title":"美国FDA建议Aldeyra深入剖析试验失败原因，未要求对Reproxalap开展额外试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1118608837","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118608837?lang=zh_cn&edition=full","pubTime":"2026-03-17 20:32","pubTimestamp":1773750724,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）近日向Aldeyra Therapeutics Inc提出关键建议，要求公司对其研发的眼科药物Reproxalap在临床试验中遭遇的失败进行深入分析。监管机构明确指出，现阶段无需开展更多临床试验，而是应将重点放在探究试验失败的根本原因上。这一建议为Aldeyra指明了下一步的研发方向，公司需从现有数据中挖掘潜在问题，为未来可能的策略调整奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALDX"],"gpt_icon":0},{"id":"1148115026","title":"Aldeyra Therapeutics收到美国FDA就Reproxalap干眼症新药申请发出的完整回复函","url":"https://stock-news.laohu8.com/highlight/detail?id=1148115026","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148115026?lang=zh_cn&edition=full","pubTime":"2026-03-17 20:31","pubTimestamp":1773750665,"startTime":"0","endTime":"0","summary":"Aldeyra Therapeutics宣布，已收到美国食品药品监督管理局（FDA）针对其Reproxalap新药申请（NDA）发出的完整回复函（CRL）。该申请旨在寻求批准Reproxalap用于治疗干眼病的体征和症状。完整回复函通常意味着FDA在当前阶段不会批准该申请，并会指出需要补充的信息或存在的问题。公司表示正在评估该函件内容，并将与FDA密切沟通，以确定后续步骤。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALDX","BK4139"],"gpt_icon":0},{"id":"1175592483","title":"美国食品药品监督管理局指出 Aldeyra Therapeutics 旗下 Reproxalap 新药申请未能证明对干眼症有效","url":"https://stock-news.laohu8.com/highlight/detail?id=1175592483","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175592483?lang=zh_cn&edition=full","pubTime":"2026-03-17 20:30","pubTimestamp":1773750657,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）近日表示，Aldeyra Therapeutics Inc 提交的 Reproxalap 新药申请（NDA）在临床试验中未能充分证明其对干眼症的治疗效果。这一结果对该公司核心产品的上市前景构成重大挑战。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALDX"],"gpt_icon":0},{"id":"2618337451","title":"Aldeyra Therapeutics, Inc.盘中异动 股价大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618337451","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618337451?lang=zh_cn&edition=full","pubTime":"2026-03-12 00:08","pubTimestamp":1773245317,"startTime":"0","endTime":"0","summary":"北京时间2026年03月12日00时08分，Aldeyra Therapeutics, Inc.股票出现波动，股价快速下跌5.19%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.88%。其相关个股中，Acurx Pharmaceuticals, Inc.、Kala Bio, Inc.、天演药业涨幅较大，Acurx Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals, Inc.、Quince Therapeutics, Inc.较为活跃，换手率分别为2240.92%、1066.56%、69.28%，振幅较大的相关个股有Acurx Pharmaceuticals, Inc.、天演药业、Kala Bio, Inc.，振幅分别为62.07%、56.62%、50.19%。Aldeyra Therapeutics, Inc.公司简介：Aldeyra Therapeutics Inc是一家生物技术公司，致力于开发和商业化下一代药物，以改善免疫介导和代谢疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312000837a461b244&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312000837a461b244&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","ALDX","BK4539"],"gpt_icon":0},{"id":"1168448428","title":"Aldeyra Therapeutics 股价在盘前交易中下跌14.3%，因其干眼症治疗药物候选获得PDUFA延期","url":"https://stock-news.laohu8.com/highlight/detail?id=1168448428","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168448428?lang=zh_cn&edition=full","pubTime":"2025-12-16 17:15","pubTimestamp":1765876524,"startTime":"0","endTime":"0","summary":"Aldeyra Therapeutics 股价在盘前交易中下跌14.3%，因为其干眼症治疗药物候选获得了PDUFA的延期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALDX"],"gpt_icon":0},{"id":"1198726583","title":"Aldeyra Therapeutics宣布Reproxalap治疗干眼症的新药申请PDUFA延期","url":"https://stock-news.laohu8.com/highlight/detail?id=1198726583","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198726583?lang=zh_cn&edition=full","pubTime":"2025-12-16 08:30","pubTimestamp":1765845015,"startTime":"0","endTime":"0","summary":"Aldeyra Therapeutics宣布Reproxalap治疗干眼症的新药申请PDUFA延期","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALDX"],"gpt_icon":0},{"id":"1163435798","title":"Aldeyra Therapeutics宣布扩大RASP平台涵盖中枢神经系统疾病，并在研发网络研讨会上提供Reproxalap进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1163435798","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163435798?lang=zh_cn&edition=full","pubTime":"2025-11-13 20:01","pubTimestamp":1763035299,"startTime":"0","endTime":"0","summary":"Aldeyra Therapeutics宣布扩大RASP平台，涵盖中枢神经系统疾病，并在研发网络研讨会上提供Reproxalap的最新进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALDX"],"gpt_icon":0},{"id":"1163818622","title":"Aldeyra Therapeutics公布酒精相关肝炎二期临床试验的积极结果，专注于Rasp产品候选管线的下一代分子","url":"https://stock-news.laohu8.com/highlight/detail?id=1163818622","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163818622?lang=zh_cn&edition=full","pubTime":"2025-10-28 19:02","pubTimestamp":1761649346,"startTime":"0","endTime":"0","summary":"Aldeyra Therapeutics公布酒精相关肝炎二期临床试验的积极结果，专注于Rasp产品候选管线的下一代分子。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALDX","BK4139"],"gpt_icon":0},{"id":"2517094655","title":"Aldeyra Therapeutics, Inc.盘中异动 早盘股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517094655","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517094655?lang=zh_cn&edition=full","pubTime":"2025-03-05 23:35","pubTimestamp":1741188932,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日23时35分，Aldeyra Therapeutics, Inc.股票出现异动，股价大幅下跌5.02%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.21%。其相关个股中，Chimerix, Inc.、Nutriband Inc C/Wts 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为865.90%、286.69%、264.06%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Nkgen Biotech, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为54.27%、42.66%、41.26%。Aldeyra Therapeutics, Inc.公司简介：Aldeyra Therapeutics Inc是一家生物技术公司，致力于开发和商业化下一代药物，以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305233532abe9c53d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305233532abe9c53d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ALDX"],"gpt_icon":0},{"id":"2516634616","title":"Aldeyra Therapeutics, Inc.盘中异动 早盘快速上涨5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634616","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516634616?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:32","pubTimestamp":1741012338,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时32分，Aldeyra Therapeutics, Inc.股票出现异动，股价大幅拉升5.48%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Entero Therapeutics Inc.、Alto Neuroscience, Inc.、Geovax Labs, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为47.32%、27.19%、22.55%，振幅较大的相关个股有Entero Therapeutics Inc.、Spruce Biosciences, Inc.、Cibus, Inc.，振幅分别为21.22%、19.25%、9.55%。Aldeyra Therapeutics, Inc.公司简介：Aldeyra Therapeutics Inc是一家生物技术公司，致力于开发和商业化下一代药物，以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223219a25d3ffb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223219a25d3ffb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALDX","LENZ","BK4139"],"gpt_icon":0},{"id":"2514332542","title":"Aldeyra Therapeutics, Inc.盘中异动 下午盘大幅跳水5.01%报6.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514332542","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514332542?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:03","pubTimestamp":1740686586,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时03分，Aldeyra Therapeutics, Inc.股票出现异动，股价快速跳水5.01%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1917.91%、336.81%、188.53%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation，振幅分别为86.14%、67.32%、55.84%。Aldeyra Therapeutics, Inc.公司简介：Aldeyra Therapeutics Inc是一家生物技术公司，致力于开发和商业化下一代药物，以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228040306abdfb72c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228040306abdfb72c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALDX","LENZ"],"gpt_icon":0},{"id":"2512161198","title":"Aldeyra Therapeutics, Inc.盘中异动 早盘快速拉升5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512161198","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512161198?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:31","pubTimestamp":1739892713,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时31分，Aldeyra Therapeutics, Inc.股票出现波动，股价急速上涨5.06%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。其相关个股中，Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为364.58%、160.21%、137.73%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、85.43%、79.17%。Aldeyra Therapeutics, Inc.公司简介：Aldeyra Therapeutics Inc是一家生物技术公司，致力于开发和商业化下一代药物，以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218233153a24aba97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218233153a24aba97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALDX","LENZ"],"gpt_icon":0},{"id":"2511579499","title":"Aldeyra Therapeutics, Inc.盘中异动 股价大涨5.23%报6.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511579499","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511579499?lang=zh_cn&edition=full","pubTime":"2025-02-14 03:18","pubTimestamp":1739474336,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日03时18分，Aldeyra Therapeutics, Inc.股票出现波动，股价快速上涨5.23%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.14%。其相关个股中，Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Dominari Holdings Inc.涨幅较大，Edesa Biotech, Inc.、Moleculin Biotech, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为3175.08%、1959.20%、1233.23%，振幅较大的相关个股有Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为733.31%、95.15%、92.30%。Aldeyra Therapeutics, Inc.公司简介：Aldeyra Therapeutics Inc是一家生物技术公司，致力于开发和商业化下一代药物，以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214031857a244e3e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214031857a244e3e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ALDX"],"gpt_icon":0},{"id":"2509201185","title":"Aldeyra Therapeutics, Inc.盘中异动 股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509201185","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509201185?lang=zh_cn&edition=full","pubTime":"2025-02-07 01:24","pubTimestamp":1738862647,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日01时24分，Aldeyra Therapeutics, Inc.股票出现波动，股价急速拉升5.08%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，Lipella Pharmaceuticals Inc.、Palatin Technologies, Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Azitra Inc较为活跃，换手率分别为6125.25%、1627.23%、164.58%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Palatin Technologies, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为125.58%、58.37%、53.02%。Aldeyra Therapeutics, Inc.公司简介：Aldeyra Therapeutics Inc是一家生物技术公司，致力于开发和商业化下一代药物，以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207012407abc4f779&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207012407abc4f779&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALDX","BK4139","LENZ"],"gpt_icon":1},{"id":"2509582512","title":"Aldeyra Therapeutics, Inc.盘中异动 大幅拉升5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509582512","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509582512?lang=zh_cn&edition=full","pubTime":"2025-02-06 03:21","pubTimestamp":1738783298,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日03时21分，Aldeyra Therapeutics, Inc.股票出现波动，股价急速上涨5.14%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.30%。其相关个股中，Invivyd, Inc.、Transcode Therapeutics, Inc.、Celularity Inc C/Wts 16/07/2026 涨幅较大，Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃，换手率分别为4627.17%、2344.35%、1750.17%，振幅较大的相关个股有Oragenics Inc.、Transcode Therapeutics, Inc.、Invivyd, Inc.，振幅分别为132.24%、99.51%、67.19%。Aldeyra Therapeutics, Inc.公司简介：Aldeyra Therapeutics Inc是一家生物技术公司，致力于开发和商业化下一代药物，以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206032138abc3b998&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206032138abc3b998&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ALDX","BK4139"],"gpt_icon":0},{"id":"2507673399","title":"Aldeyra Therapeutics, Inc.盘中异动 快速拉升5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507673399","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507673399?lang=zh_cn&edition=full","pubTime":"2025-01-31 00:27","pubTimestamp":1738254438,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日00时27分，Aldeyra Therapeutics, Inc.股票出现波动，股价急速上涨5.02%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Tectonic Therapeutic, Inc.、Kazia Therapeutics Limited、Alterity Therapeutics Limited涨幅较大，Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃，换手率分别为1639.80%、233.42%、212.18%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Alterity Therapeutics Limited、Immatics N V C/Wts 01/07/2025 ，振幅分别为65.98%、61.86%、56.41%。Aldeyra Therapeutics, Inc.公司简介：Aldeyra Therapeutics Inc是一家生物技术公司，致力于开发和商业化下一代药物，以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131002718abbd613e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131002718abbd613e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ALDX"],"gpt_icon":0},{"id":"2507528072","title":"Aldeyra Therapeutics, Inc.盘中异动 下午盘股价大涨5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507528072","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507528072?lang=zh_cn&edition=full","pubTime":"2025-01-29 04:23","pubTimestamp":1738095835,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日04时23分，Aldeyra Therapeutics, Inc.股票出现波动，股价快速上涨5.37%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。Aldeyra Therapeutics, Inc.公司简介：Aldeyra Therapeutics Inc是一家生物技术公司，致力于开发和商业化下一代药物，以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012904235696131a4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012904235696131a4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALDX","LENZ","BK4139"],"gpt_icon":0},{"id":"2504947777","title":"Aldeyra Therapeutics, Inc.盘中异动 临近收盘快速下挫5.06%报4.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504947777","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504947777?lang=zh_cn&edition=full","pubTime":"2025-01-17 04:34","pubTimestamp":1737059689,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日04时34分，Aldeyra Therapeutics, Inc.股票出现波动，股价快速下挫5.06%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.01%。其相关个股中，Surrozen Inc C/Wts 01/08/2031 、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Aeon Biopharma, Inc.涨幅较大，Aditxt, Inc.、Phio Pharmaceuticals Corp.、Aeon Biopharma, Inc.较为活跃，换手率分别为1956.21%、1217.53%、815.60%，振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Aeon Biopharma, Inc.，振幅分别为152.94%、131.33%、104.84%。Aldeyra Therapeutics, Inc.公司简介：Aldeyra Therapeutics Inc是一家生物技术公司，致力于开发和商业化下一代药物，以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501170434499868d37e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501170434499868d37e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALDX","LENZ","BK4139"],"gpt_icon":0},{"id":"2503808125","title":"Aldeyra Therapeutics, Inc.盘中异动 临近午盘快速跳水5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503808125","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503808125?lang=zh_cn&edition=full","pubTime":"2025-01-14 00:30","pubTimestamp":1736785814,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日00时30分，Aldeyra Therapeutics, Inc.股票出现异动，股价大幅下挫5.26%。Aldeyra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.67%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.较为活跃，换手率分别为11757.47%、6474.34%、454.52%，振幅较大的相关个股有Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.，振幅分别为336.09%、216.61%、185.36%。Aldeyra Therapeutics, Inc.公司简介：Aldeyra Therapeutics Inc是一家生物技术公司，致力于开发和商业化下一代药物，以改善免疫介导疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011400301496026784&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011400301496026784&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ALDX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aldeyra.com;ir.aldeyra.com","stockEarnings":[{"period":"1week","weight":-0.4728},{"period":"1month","weight":-0.5495},{"period":"3month","weight":-0.5584},{"period":"6month","weight":-0.5549},{"period":"1year","weight":-0.6611},{"period":"ytd","weight":-0.5695}],"compareEarnings":[{"period":"1week","weight":-0.0204},{"period":"1month","weight":-0.0494},{"period":"3month","weight":-0.0474},{"period":"6month","weight":-0.0087},{"period":"1year","weight":0.1621},{"period":"ytd","weight":-0.0389}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aldeyra Therapeutics, Inc.于2004年8月13日在特拉华州注册成立。该公司是一家临床阶段的生物技术公司，致力于发现和开发旨在治疗免疫介导性疾病的创新疗法。其方法侧重于调节蛋白质系统，后期候选药物包括用于干眼病和过敏性结膜炎的reproxalap，以及用于视网膜疾病的ADX-2191。","yearOnYearQuotes":[{"month":1,"riseRate":0.583333,"avgChangeRate":0.071524},{"month":2,"riseRate":0.583333,"avgChangeRate":-0.000501},{"month":3,"riseRate":0.416667,"avgChangeRate":-0.04041},{"month":4,"riseRate":0.454545,"avgChangeRate":-0.007872},{"month":5,"riseRate":0.363636,"avgChangeRate":0.012368},{"month":6,"riseRate":0.333333,"avgChangeRate":0.032526},{"month":7,"riseRate":0.583333,"avgChangeRate":0.052566},{"month":8,"riseRate":0.5,"avgChangeRate":0.050447},{"month":9,"riseRate":0.5,"avgChangeRate":0.169785},{"month":10,"riseRate":0.416667,"avgChangeRate":-0.091942},{"month":11,"riseRate":0.666667,"avgChangeRate":0.079554},{"month":12,"riseRate":0.416667,"avgChangeRate":-0.031913}],"exchange":"NASDAQ","name":"Aldeyra Therapeutics Inc","nameEN":"Aldeyra Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aldeyra Therapeutics Inc(ALDX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Aldeyra Therapeutics Inc(ALDX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Aldeyra Therapeutics Inc,ALDX,Aldeyra Therapeutics Inc股票,Aldeyra Therapeutics Inc股票老虎,Aldeyra Therapeutics Inc股票老虎国际,Aldeyra Therapeutics Inc行情,Aldeyra Therapeutics Inc股票行情,Aldeyra Therapeutics Inc股价,Aldeyra Therapeutics Inc股市,Aldeyra Therapeutics Inc股票价格,Aldeyra Therapeutics Inc股票交易,Aldeyra Therapeutics Inc股票购买,Aldeyra Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aldeyra Therapeutics Inc(ALDX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Aldeyra Therapeutics Inc(ALDX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}